TARSUS PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
TARSUS PHARMACEUTICALS, INC. (TARS) had Shares Outstanding (Cover Page) of 43.88 million shares as of 2026-07-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-30: Entity Common Stock, Shares Outstanding 43.88M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 43.02M shares.
- 2026-02-17: Entity Common Stock, Shares Outstanding 42.56M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 42.45M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 43.88M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 43.02M shares 10-Q · filed 2026-05-06 |
| 2026-02-17 | 42.56M shares 10-K · filed 2026-02-23 |
| 2025-10-29 | 42.45M shares 10-Q · filed 2025-11-04 |
| 2025-07-31 | 42.21M shares 10-Q · filed 2025-08-06 |
| 2025-04-24 | 42.01M shares 10-Q · filed 2025-05-01 |
| 2025-02-19 | 38.38M shares 10-K · filed 2025-02-25 |
| 2024-11-07 | 38.23M shares 10-Q · filed 2024-11-13 |
| 2024-08-02 | 38.04M shares 10-Q · filed 2024-08-08 |
| 2024-05-02 | 37.78M shares 10-Q · filed 2024-05-08 |
| 2024-02-21 | 34.22M shares 10-K · filed 2024-02-27 |
| 2023-11-03 | 33.10M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 32.62M shares 10-Q · filed 2023-08-10 |
| 2023-05-04 | 26.80M shares 10-Q · filed 2023-05-09 |
| 2023-03-09 | 26.73M shares 10-K · filed 2023-03-17 |
| 2022-11-07 | 26.67M shares 10-Q · filed 2022-11-09 |
| 2022-08-05 | 26.66M shares 10-Q · filed 2022-08-11 |
| 2022-05-04 | 20.73M shares 10-Q · filed 2022-05-11 |
| 2022-03-09 | 20.71M shares 10-K · filed 2022-03-14 |
| 2021-11-04 | 20.68M shares 10-Q · filed 2021-11-10 |
| 2021-08-01 | 20.57M shares 10-Q · filed 2021-08-05 |
| 2021-05-01 | 20.52M shares 10-Q · filed 2021-05-11 |
| 2021-03-19 | 20.50M shares 10-K · filed 2021-03-31 |
| 2020-11-23 | 20.32M shares 10-Q · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |